Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
A Phase 1 study to assess the bioavailability and pharmacokinetics of a 600 mg immediate
release tablet formulation of lefamulin when administered to fed and fasted healthy subjects
in comparison to an intravenous formulation and a capsule formulation.